J&J first-quarter results
This article was originally published in The Rose Sheet
Executive Summary
The strong performance of skin-care lines Aveeno and Clean & Clear helped drive worldwide consumer sales up 48.5% to $3.5 bil. for the first quarter 2007, company announces April 17. J&J's combined consumer business - which includes skin care, baby and kids care, oral care, OTCs and nutritionals and women's health - increased 41.7% domestically to $1.6 bil. and 54.9% internationally to $1.9 bil. for the quarter, firm says. In the U.S., skin-care sales rose 13% to $357 mil., baby and kids care increased 5% to $109 mil., and oral care booked $203 mil. in revenue. J&J acquired Pfizer Consumer Healthcare in December 2006 (1"The Rose Sheet" Jan. 1, 2007, In Brief)...
|
The strong performance of skin-care lines Aveeno and Clean & Clear helped drive worldwide consumer sales up 48.5% to $3.5 bil. for the first quarter 2007, company announces April 17. J&J's combined consumer business - which includes skin care, baby and kids care, oral care, OTCs and nutritionals and women's health - increased 41.7% domestically to $1.6 bil. and 54.9% internationally to $1.9 bil. for the quarter, firm says. In the U.S., skin-care sales rose 13% to $357 mil., baby and kids care increased 5% to $109 mil., and oral care booked $203 mil. in revenue. J&J acquired Pfizer Consumer Healthcare in December 2006 (1 'The Rose Sheet' Jan. 1, 2007, In Brief).... |